Watch Ticker

Journey Medical Corporation Common Stock

Go to Journey Medical Corporation Common Stock Website

$7.21

0.07 (0.98%)

Live

Previous Close

$7.21

Day Range

$7.05 - $7.23

Previous Day Range

$6.9 - $7.26

Market Cap

$166.3 million USD

Day Vol.

81577

Previous Day Vol.

84946

Currency

USD

Primary Exchange

Nasdaq

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-a...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

Journey Medical Corporation announced that the FDA has approved Emrosi™, a new treatment for inflammatory lesions of rosacea in adults. The approval is supported by positive data from the company's Phase 3 clinical trials.

Related tickers: DERM.

Read Full Article

Journey Medical Corporation - Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, announced today that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase on Tuesday, May 21, 2024, at 1:00 p.m. ET.

Related tickers: DERM, FBIO.

Read Full Article

Trending Tickers

Please sign in to view